Broad-Spectrum Antiviral Drug HSRx 431™ Tests Effective Against Zika Virus

TUCSON, Arizona, Sept. 6, 2016 /PRNewswire/ — HSRx Biopharmaceutical, a leading developer of polyfunctional-powered combination drugs for infectious and age-related chronic disease conditions, confirmed its orally administered broad-spectrum antiviral drug candidate, HSRx 431™, is effective against the Zika virus. HSRx expects to begin human trials early in 2017 and will seek accelerated drug approval from […]

Read More »

Meridian Malaria Test Wins Prestigious Innovation Award

illumigene® Malaria Receives 1st Place Award at the Journées Internationales de Biologie /Association des Colloques Nationaux des Biologistes Conference in Paris CINCINNATI, Aug. 30, 2016 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ:VIVO) was awarded 1st place for innovation in emergency treatment and point-of-care testing for its illumigene® Malaria test at the 2016 JIB/ACNBH Conference this summer. […]

Read More »

GeneOne Life Science Announces Full Enrollment of First-In-Human Study of MERS Vaccine

SEOUL, South Korea, Aug. 08, 2016 (GLOBE NEWSWIRE) — GeneOne Life Science Inc. (KSE:011000) today announced that enrollment has been completed of the first-in-human clinical trial of the GLS-5300 vaccine for MERS (Middle East Respiratory Syndrome) with a total of 75 subjects. GeneOne Life Science and U.S.-based Inovio Pharmaceuticals (NASDAQ:INO) are co-developing the vaccine.  This […]

Read More »